nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A7—Vincristine—muscle cancer	0.133	0.141	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.133	0.141	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—muscle cancer	0.106	0.112	CbGbCtD
Alfentanil—CYP3A5—Vincristine—muscle cancer	0.0999	0.106	CbGbCtD
Alfentanil—CYP3A5—Etoposide—muscle cancer	0.0916	0.0971	CbGbCtD
Alfentanil—ALB—Methotrexate—muscle cancer	0.0753	0.0799	CbGbCtD
Alfentanil—ABCB1—Vincristine—muscle cancer	0.065	0.069	CbGbCtD
Alfentanil—ABCB1—Etoposide—muscle cancer	0.0596	0.0632	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—muscle cancer	0.0406	0.0431	CbGbCtD
Alfentanil—ABCB1—Methotrexate—muscle cancer	0.0394	0.0418	CbGbCtD
Alfentanil—CYP3A4—Vincristine—muscle cancer	0.039	0.0413	CbGbCtD
Alfentanil—CYP3A4—Etoposide—muscle cancer	0.0357	0.0379	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—muscle cancer	0.0244	0.0258	CbGbCtD
Alfentanil—Myoclonus—Vincristine—muscle cancer	0.0022	0.0383	CcSEcCtD
Alfentanil—Laryngospasm—Etoposide—muscle cancer	0.00144	0.025	CcSEcCtD
Alfentanil—Apnoea—Etoposide—muscle cancer	0.00127	0.022	CcSEcCtD
Alfentanil—Cardiac arrest—Vincristine—muscle cancer	0.000915	0.0159	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Etoposide—muscle cancer	0.000806	0.014	CcSEcCtD
Alfentanil—Apnoea—Methotrexate—muscle cancer	0.000759	0.0132	CcSEcCtD
Alfentanil—Dermatitis atopic—Doxorubicin—muscle cancer	0.000753	0.0131	CcSEcCtD
Alfentanil—Cardiac arrest—Etoposide—muscle cancer	0.000741	0.0129	CcSEcCtD
Alfentanil—Injection site pain—Doxorubicin—muscle cancer	0.000682	0.0119	CcSEcCtD
Alfentanil—Chills—Dactinomycin—muscle cancer	0.000669	0.0116	CcSEcCtD
Alfentanil—Bronchospasm—Etoposide—muscle cancer	0.000663	0.0115	CcSEcCtD
Alfentanil—Connective tissue disorder—Vincristine—muscle cancer	0.000654	0.0114	CcSEcCtD
Alfentanil—Erythema—Dactinomycin—muscle cancer	0.000649	0.0113	CcSEcCtD
Alfentanil—Cardiac disorder—Vincristine—muscle cancer	0.000618	0.0107	CcSEcCtD
Alfentanil—Angiopathy—Vincristine—muscle cancer	0.000604	0.0105	CcSEcCtD
Alfentanil—Mediastinal disorder—Vincristine—muscle cancer	0.0006	0.0104	CcSEcCtD
Alfentanil—Dyskinesia—Doxorubicin—muscle cancer	0.000593	0.0103	CcSEcCtD
Alfentanil—Mental disorder—Vincristine—muscle cancer	0.000583	0.0101	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—muscle cancer	0.000557	0.00968	CcSEcCtD
Alfentanil—Agitation—Vincristine—muscle cancer	0.000533	0.00925	CcSEcCtD
Alfentanil—Eye disorder—Etoposide—muscle cancer	0.000504	0.00876	CcSEcCtD
Alfentanil—Convulsion—Vincristine—muscle cancer	0.000502	0.00873	CcSEcCtD
Alfentanil—Cardiac disorder—Etoposide—muscle cancer	0.000501	0.0087	CcSEcCtD
Alfentanil—Hypertension—Vincristine—muscle cancer	0.0005	0.00869	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—muscle cancer	0.000493	0.00856	CcSEcCtD
Alfentanil—Angiopathy—Etoposide—muscle cancer	0.000489	0.0085	CcSEcCtD
Alfentanil—Immune system disorder—Etoposide—muscle cancer	0.000487	0.00846	CcSEcCtD
Alfentanil—Mediastinal disorder—Etoposide—muscle cancer	0.000486	0.00845	CcSEcCtD
Alfentanil—Chills—Etoposide—muscle cancer	0.000484	0.00841	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000482	0.00838	CcSEcCtD
Alfentanil—Anaphylactic shock—Vincristine—muscle cancer	0.000473	0.00822	CcSEcCtD
Alfentanil—Nervous system disorder—Vincristine—muscle cancer	0.000464	0.00806	CcSEcCtD
Alfentanil—Hyperhidrosis—Vincristine—muscle cancer	0.000457	0.00795	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—muscle cancer	0.000456	0.00793	CcSEcCtD
Alfentanil—Pain—Dactinomycin—muscle cancer	0.000453	0.00787	CcSEcCtD
Alfentanil—Hypotension—Vincristine—muscle cancer	0.000442	0.00768	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—muscle cancer	0.000436	0.00758	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—muscle cancer	0.000419	0.00727	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000418	0.00726	CcSEcCtD
Alfentanil—Loss of consciousness—Etoposide—muscle cancer	0.000413	0.00717	CcSEcCtD
Alfentanil—Cough—Etoposide—muscle cancer	0.00041	0.00712	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vincristine—muscle cancer	0.000408	0.0071	CcSEcCtD
Alfentanil—Fatigue—Vincristine—muscle cancer	0.000408	0.00709	CcSEcCtD
Alfentanil—Convulsion—Etoposide—muscle cancer	0.000407	0.00707	CcSEcCtD
Alfentanil—Hypertension—Etoposide—muscle cancer	0.000405	0.00704	CcSEcCtD
Alfentanil—Pain—Vincristine—muscle cancer	0.000405	0.00703	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000397	0.0069	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—muscle cancer	0.00039	0.00678	CcSEcCtD
Alfentanil—Confusional state—Etoposide—muscle cancer	0.000386	0.00671	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—muscle cancer	0.000384	0.00668	CcSEcCtD
Alfentanil—Anaphylactic shock—Etoposide—muscle cancer	0.000383	0.00666	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—muscle cancer	0.00038	0.0066	CcSEcCtD
Alfentanil—Tachycardia—Etoposide—muscle cancer	0.000374	0.0065	CcSEcCtD
Alfentanil—Body temperature increased—Vincristine—muscle cancer	0.000374	0.0065	CcSEcCtD
Alfentanil—Skin disorder—Etoposide—muscle cancer	0.000372	0.00647	CcSEcCtD
Alfentanil—Hyperhidrosis—Etoposide—muscle cancer	0.00037	0.00644	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—muscle cancer	0.00036	0.00625	CcSEcCtD
Alfentanil—Hypotension—Etoposide—muscle cancer	0.000358	0.00622	CcSEcCtD
Alfentanil—Hypersensitivity—Vincristine—muscle cancer	0.000349	0.00606	CcSEcCtD
Alfentanil—Somnolence—Etoposide—muscle cancer	0.000341	0.00592	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—muscle cancer	0.000339	0.0059	CcSEcCtD
Alfentanil—Asthenia—Vincristine—muscle cancer	0.000339	0.0059	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—muscle cancer	0.000337	0.00585	CcSEcCtD
Alfentanil—Rash—Dactinomycin—muscle cancer	0.000334	0.0058	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Etoposide—muscle cancer	0.000331	0.00575	CcSEcCtD
Alfentanil—Fatigue—Etoposide—muscle cancer	0.00033	0.00574	CcSEcCtD
Alfentanil—Pain—Etoposide—muscle cancer	0.000328	0.00569	CcSEcCtD
Alfentanil—Feeling abnormal—Etoposide—muscle cancer	0.000316	0.00549	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—muscle cancer	0.000314	0.00546	CcSEcCtD
Alfentanil—Dizziness—Vincristine—muscle cancer	0.000313	0.00543	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—muscle cancer	0.000312	0.00541	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—muscle cancer	0.000311	0.00541	CcSEcCtD
Alfentanil—Urticaria—Etoposide—muscle cancer	0.000304	0.00529	CcSEcCtD
Alfentanil—Body temperature increased—Etoposide—muscle cancer	0.000303	0.00526	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—muscle cancer	0.000302	0.00525	CcSEcCtD
Alfentanil—Vomiting—Vincristine—muscle cancer	0.000301	0.00523	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—muscle cancer	0.0003	0.00521	CcSEcCtD
Alfentanil—Rash—Vincristine—muscle cancer	0.000298	0.00518	CcSEcCtD
Alfentanil—Dermatitis—Vincristine—muscle cancer	0.000298	0.00518	CcSEcCtD
Alfentanil—Headache—Vincristine—muscle cancer	0.000296	0.00515	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—muscle cancer	0.000294	0.00511	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—muscle cancer	0.000293	0.00509	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—muscle cancer	0.000292	0.00507	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—muscle cancer	0.000291	0.00506	CcSEcCtD
Alfentanil—Chills—Methotrexate—muscle cancer	0.00029	0.00504	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—muscle cancer	0.000285	0.00495	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—muscle cancer	0.000283	0.00492	CcSEcCtD
Alfentanil—Hypersensitivity—Etoposide—muscle cancer	0.000282	0.00491	CcSEcCtD
Alfentanil—Erythema—Methotrexate—muscle cancer	0.000281	0.00489	CcSEcCtD
Alfentanil—Nausea—Vincristine—muscle cancer	0.000281	0.00488	CcSEcCtD
Alfentanil—Asthenia—Etoposide—muscle cancer	0.000275	0.00478	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—muscle cancer	0.000275	0.00478	CcSEcCtD
Alfentanil—Pruritus—Etoposide—muscle cancer	0.000271	0.00471	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—muscle cancer	0.00027	0.00468	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—muscle cancer	0.000265	0.00461	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—muscle cancer	0.000261	0.00454	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—muscle cancer	0.00026	0.00451	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—muscle cancer	0.000254	0.00441	CcSEcCtD
Alfentanil—Dizziness—Etoposide—muscle cancer	0.000253	0.0044	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—muscle cancer	0.000253	0.00439	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—muscle cancer	0.000252	0.00438	CcSEcCtD
Alfentanil—Chills—Doxorubicin—muscle cancer	0.000251	0.00436	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—muscle cancer	0.00025	0.00434	CcSEcCtD
Alfentanil—Cough—Methotrexate—muscle cancer	0.000245	0.00426	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—muscle cancer	0.000245	0.00426	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—muscle cancer	0.000244	0.00423	CcSEcCtD
Alfentanil—Vomiting—Etoposide—muscle cancer	0.000244	0.00423	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—muscle cancer	0.000244	0.00423	CcSEcCtD
Alfentanil—Rash—Etoposide—muscle cancer	0.000242	0.0042	CcSEcCtD
Alfentanil—Dermatitis—Etoposide—muscle cancer	0.000241	0.00419	CcSEcCtD
Alfentanil—Headache—Etoposide—muscle cancer	0.00024	0.00417	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000238	0.00413	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—muscle cancer	0.000231	0.00402	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—muscle cancer	0.00023	0.00399	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—muscle cancer	0.000229	0.00399	CcSEcCtD
Alfentanil—Nausea—Etoposide—muscle cancer	0.000228	0.00395	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—muscle cancer	0.000225	0.00391	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—muscle cancer	0.000224	0.00389	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—muscle cancer	0.000223	0.00387	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—muscle cancer	0.000222	0.00386	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—muscle cancer	0.000214	0.00373	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—muscle cancer	0.000214	0.00372	CcSEcCtD
Alfentanil—Cough—Doxorubicin—muscle cancer	0.000212	0.00369	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—muscle cancer	0.000211	0.00367	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—muscle cancer	0.00021	0.00365	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000206	0.00358	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—muscle cancer	0.000204	0.00355	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—muscle cancer	0.0002	0.00348	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—muscle cancer	0.000199	0.00345	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000198	0.00344	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—muscle cancer	0.000198	0.00344	CcSEcCtD
Alfentanil—Pain—Methotrexate—muscle cancer	0.000196	0.00341	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—muscle cancer	0.000195	0.00339	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—muscle cancer	0.000194	0.00337	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—muscle cancer	0.000193	0.00335	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—muscle cancer	0.000192	0.00334	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—muscle cancer	0.000189	0.00329	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—muscle cancer	0.000186	0.00323	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—muscle cancer	0.000182	0.00317	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—muscle cancer	0.000181	0.00315	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—muscle cancer	0.000177	0.00307	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000172	0.00298	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—muscle cancer	0.000171	0.00298	CcSEcCtD
Alfentanil—Pain—Doxorubicin—muscle cancer	0.00017	0.00295	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—muscle cancer	0.000169	0.00294	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—muscle cancer	0.000165	0.00286	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—muscle cancer	0.000164	0.00285	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—muscle cancer	0.000162	0.00282	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—muscle cancer	0.000158	0.00274	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—muscle cancer	0.000157	0.00273	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—muscle cancer	0.000152	0.00264	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—muscle cancer	0.000146	0.00254	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—muscle cancer	0.000146	0.00254	CcSEcCtD
Alfentanil—Rash—Methotrexate—muscle cancer	0.000145	0.00251	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—muscle cancer	0.000145	0.00251	CcSEcCtD
Alfentanil—Headache—Methotrexate—muscle cancer	0.000144	0.0025	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—muscle cancer	0.000143	0.00248	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—muscle cancer	0.000141	0.00244	CcSEcCtD
Alfentanil—Nausea—Methotrexate—muscle cancer	0.000136	0.00237	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—muscle cancer	0.000131	0.00228	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—muscle cancer	0.000126	0.0022	CcSEcCtD
Alfentanil—Rash—Doxorubicin—muscle cancer	0.000125	0.00218	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—muscle cancer	0.000125	0.00218	CcSEcCtD
Alfentanil—Headache—Doxorubicin—muscle cancer	0.000125	0.00216	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—muscle cancer	0.000118	0.00205	CcSEcCtD
